Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer

Journal of the National Cancer Institute

Volumn 88, Issue 19, 1996, Pages 1361-1368

  Burger, Robert A ^a,b   Monk, Bradley J ^a,b   Kurosaki, Tom ^a   Anton Culver, Hoda ^a   Vasilev, Steven A ^a,b   Berman, Michael L ^c   Wilczynski, Sharon P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DNA SEQUENCE; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PROGNOSIS; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

EID: 0029759768     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.19.1361     Document Type: Article

References (42)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
3. Bosch FX, Manos M, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comment citation in Medline]. J Natl Cancer Inst 1995;87:796-802.
4. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
5. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
6. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12.
7. Franco EL. Measurement errors in epidemiological studies of human papillomavirus and cervical cancer. IARC Sci Publ 1992;719:181-97.
8. Schiffman MH, Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia [see comment citation in Medline]. Cancer Res 1994;54(7 Suppl): 1944s-47s.
9. Monk BJ, Cook N, Ahn C, Vasilev SA, Berman ML, Wilczynski SP. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn Mol Pathol 1994;3:283-91.
10. Walker J, Bloss JD, Liao SY, Berman M, Bergen S, Wilczynski SP. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 1989;74:781-5.
11. Barnes W, Delgado G, Kurman RJ, Petrilli ES, Smith DM, Ahmed S, et al. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988;29:267-73.
12. Burnett AF, Barnes WA, Johnson JC, Grendys E, Willett GD, Barter JF, et al. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer. Gynecol Oncol 1992;47:343-7.
13. Zhang J, Rose BR, Thompson CH, Jarrett C, Russell P, Houghton RS, et al. Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer. Gynecol Oncol 1995;57:170-7.
14. Rose BR, Thompson CH, Simpson JM, Jarrett CS, Elliott PM, Tattersall MH, et al. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol 1995;173:1461-8.
15. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16. Hum Pathol 1993;24:432-7.
16. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159:293-6.
17. Barbosa MS, Schlegel R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989;4:1529-32.
18. Villa LL, Schlegel R. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 1991;181:374-7.
19. King LA, Tase T, Twiggs LB, Okagaki T, Savage JE, Adcock LL, et al. Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer 1989;63:897-900.
20. Chen TM, Chen CA, Wu CC, Huang SC, Chang CF, Hsieh CY. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer 1994;57:181-4.
21. Ip EW, Collins RJ, Srivastava G, Cheung AN, Wong LC. Human papillomavirus and its prognostic significance in invasive carcinoma of the cervix in young patients. Int J Gynecol Pathol 1992;11:258-65.
22. Rose BR, Thompson CH, Cossart YE, Elliot PE, Tattersall MH. Papillomavirus DNA and prognosis in cervical cancer [letter] [see comment citation in Medline]. Lancet 1991;337:489.
23. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA [see comment citation in Medline]. Lancet 1990;335:1171-4.
24. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-3.
25. Ikenberg H, Sauerbrei W, Schottmuller U, Spitz C, Pfleiderer A. Human papillomavirus DNA in cervical carcinoma - correlation with clinical data and influence on prognosis. Int J Cancer 1994;59:322-6.
26. DeBritton RC, Hildesheim A, De Lao SL, Brinton LA, Sathya P, Reeves WC. Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol 1993;81:19-24.
27. Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DG, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego (CA): Academic Press, 1990:356-67.
28. Dallas PB, Flanagan JL, Nightingale BN, Morris BJ. Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol 1989;27:105-11.
29. FIGO Cancer Committee. Staging announcement: FIGO Cancer Committee. Gynecol Oncol 1986;25:383-5.
30. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer-Verlag, 1994:279-326.
31. DiSaia PJ, Creasman WT. Invasive cervical cancer. In: DiSaia PJ, Creasman WT, editors. Clinical gynecologic oncology. St. Louis (MO): Mosby Year Book, 1993:58-125.
32. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma [see comment citation in Medline]. Gynecol Oncol 1994;54:4-9.
33. Wilczynski SP, Bergen S, Walker J, Liao SY, Pearlman LF. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types [see comment citation in Medline]. Hum Pathol 1988; 19:697-704.
34. Wilczynski SP, Walker J, Liao SY, Bergen S, Berman M. Adenocarcinoma of the cervix associated with human papillomavirus. Cancer 1988;62:1331-6.
35. Muller M, Gissmann L, Cristiano RJ, Sun XY, Frazer IH, Jenson AB, et al. Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol 1995;69:948-54.
36. Mack DH, Laimins LA. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl Acad Sci USA 1991;88:9102-6.
37. Thierry F, Spyrou G, Yaniv M, Howley P. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992;66:3740-8.
38. Burger MP, Hollema H, Gouw AS, Pieters WJ, Quint WG. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality [see comment citations in Medline]. BMJ 1993; 306:749-52.
39. Waggoner SE, Wang X. Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells. Gynecol Oncol 1994;55:91-5.
40. Franco EL. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence. Cancer Epidemiol Biomarkers Prev 1992;1:499-504.
41. Romanczuk H, Villa LL, Schlegel R, Howley PM. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J Virol 1991;65:2739-44.
42. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-62.